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Abstract
Obstructive sleep apnea (OSA) is a prevalent condition and strongly associated with metabolic disorders. Sleep
fragmentation (SF) is a major consequence of OSA, but its contribution to OSA-related morbidities is not known. We
hypothesized that SF causes specific perturbations in transcriptional networks of visceral fat cells, leading to systemic
metabolic disturbances. We simultaneously profiled visceral adipose tissue mRNA and miRNA expression in mice exposed to
6 hours of SF during sleep, and developed a new computational framework based on gene set enrichment and network
analyses to merge these data. This approach leverages known gene product interactions and biologic pathways to
interrogate large-scale gene expression profiling data. We found that SF induced the activation of several distinct pathways,
including those involved in insulin regulation and diabetes. Our integrative methodology identified putative controllers and
regulators of the metabolic response during SF. We functionally validated our findings by demonstrating altered glucose
and lipid homeostasis in sleep-fragmented mice. This is the first study to link sleep fragmentation with widespread
disruptions in visceral adipose tissue transcriptome, and presents a generalizable approach to integrate mRNA-miRNA
information for systematic mapping of regulatory networks.
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Introduction
Obstructive sleep apnea (OSA) is a highly prevalent disorder in
adults and children [1–3] and associated with significant cognitive,
metabolic, and cardiovascular morbidities [4–8]. OSA is charac-
terized by recurrent collapse of the upper airway during sleep,
leading to intermittent hypoxia and sleep fragmentation (SF).
There is accumulating evidence that OSA is strongly linked to
metabolic dysregulation, independent of obesity [9,10]. Further-
more, fragmentation of sleep architecture is being recognized as an
important contributor to OSA-related morbidities and can cause
altered glucose homeostasis even in normal subjects [11]. SF may
promote the adverse metabolic consequences of sleep apnea by
perturbing normal visceral adipose tissue function and altering
insulin sensitivity [12,13], but the biological effects of SF on fat
tissue are not known. Since visceral fat tissue depots are critical
regulators of metabolism [14,15], understanding the pathophys-
iologic consequences of SF on adipocyte biology is a crucial step in
elucidating mechanisms linking OSA with metabolic dysregula-
tion.
The advent of transcriptional profiling using mRNA micro-
arrays has yielded important insights into the function of adipose
tissue under various conditions [16–18]. More recently, micro-
RNAs (miRNAs)—small, noncoding single strand RNAs abundant
in eukaryotic cells—have emerged as central regulators of gene
expression, exerting their influence through partial base-pairing
with their target mRNAs that leads to their degradation or
repression of translation [19,20]. miRNAs are key effectors of
many biological processes including adipocyte differentiation,
metabolism, and insulin homeostasis [21–24]. A few studies have
exploited miRNA profiling to define the transcriptional response
of adipose tissue under normal and disease conditions [25–28], but
no such efforts have been reported in OSA patients or in animal
models of sleep apnea. The ability to simultaneously interrogate
mRNA and miRNA gene expression from the same tissue is a
promising venue for constructing gene regulatory networks in
complex disorders, and a number of strategies for combining
miRNA with mRNA have been proposed [29–32]. To our
knowledge, this integrative approach has not been applied to
investigate the effects of SF on the transcriptional circuitry of
adipocytes. In this study, we induced SF in mice and developed a
novel framework to mesh information from large-scale mRNA-
miRNA profiling of visceral adipose tissue in order to systemat-
ically identify perturbed pathways within the context of their
putative regulatory miRNAs. We validated our approach by
demonstrating the functional relevance of a highly enriched
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homeostasis and insulin resistance in sleep-fragmented mice.
Materials and Methods
Animal experiments
Male C57BJ/6L mice (Jackson Laboratory, Bar Harbor, Maine)
of 10 weeks of age were used in this study. These mice were
housed in 12-hour light/dark cycle (lights on at 7 a.m. to 7 p.m.) in
constant temperature (2661uC) with ad libitum access to food and
water. At the end of the experimental period, the mice underwent
brief anesthesia using carbon dioxide (1–2 min) and were
euthanized immediately by cervical dislocation. Abdominal cavity
was surgically opened and white (visceral) adipose tissue was
dissected from the epididymis within ,5 min, immediately frozen
in liquid nitrogen, and stored at 280uC until RNA extraction. All
protocols were approved by the Institutional Animal Care and Use
Committee and are in close agreement with the National Institutes
of Health Guide in the Care and Use of Animals. All efforts were made
to minimize animal suffering and to reduce the number of animals
used.
Sleep fragmentation (SF)
Using a rodent model of sleep fragmentation recently developed
and validated in our laboratory [33,34], sleep was disrupted by the
movement of an automated bar for the duration of exposure (6 h).
This method prevents the need for human contact and interven-
tion, introduction of foreign objects or touching of the animals
during sleep, and is therefore superior to other existing methods of
sleep disruption. To induce moderate to severe sleep fragmenta-
tion (mimicking patients with sleep apnea), we chose a 2-minute
interval between each sweep, implemented during the light period
(7 a.m. to 7 p.m.) with no activation of the sweeper during the
night period (7 p.m. to 7 a.m.). Of note, two mice were housed in
each sleep fragmenter cage to minimize isolation stress.
RNA isolation
Total RNA and miRNA were isolated from the same visceral fat
adipose tissues of each animal (SF: n=8, control: n=8). Total
RNA was isolated using automated RNA extraction (Promega,
Madison, WI) and DNase treated according to manufacturer’s
protocol. miRNA was isolated using miRNeasy Mini kit (Qiagen,
Turnberry Lane, Valencia, CA.). The RNA quality and integrity
were determined using the Eukaryote Total RNA Nano 6000
LabChip assay (Agilent Technologies) on the Agilent 2100
Bioanalyzer. The quality of miRNA was determined using Agilent
Small RNA Kit according to the manufacture’s protocol. Both
total RNA and miRNA samples were quantified on a Nanodrop
2000 (Ambion, Austin, TX).
Microarray experiments
mRNA microarrays. Whole-genome mouse Agilent micro-
arrays were used to profile visceral fat gene expression during SF
and control conditions. Purified total RNA (500 ng) was processed
for labeling using the Low RNA Input Fluorescent Linear
Amplification Kit (Agilent Technologies, Santa Clara, CA). Equal
quantities of total RNA were labeled with each reaction containing
50 ng of total RNA and 2 ml (34 pg) of RNA spike-in control.
Cyanine 3-labeled CTPs were obtained from PerkinElmer/NEN
Life Sciences (Boston, MA). Agilent’s Low Input Fluorescent
Linear Amplification kit was used to generate cRNA for one color
as we have previously described [35]. The quality of each cRNA
sample was evaluated using 2100 Bioanalyzer (Agilent Technol-
ogies, Santa Clara, CA). Each sample was hybridized to an Agilent
oligonucleotide microarray for a total of 16 independent
experiments. The microarray slides were scanned using Agilent
dual-laser Microarray Scanner and the digitized images were
acquired and processed using Agilent Feature Extraction (FE)
software v.9.5. One of the mRNA microarray experiments (in the
control group) failed our hybridization quality assessment and was
excluded from further analysis. Background-subtracted intensities
were normalized using the quantile method across all remaining
15 microarray experiments.
miRNA microarrays. Each sample was prepared according
to the Agilent’s miRNA (627 mouse miRNAs and 39 mouse viral
miRNA) using the one-color technique in accordance with the
manufacturer’s instructions. The samples were profiled on the
Agilent Mouse miRNA Microarray (Agilent Technologies),
consisting of 60-mer DNA probes synthesized in situ that represent
620 mouse miRNA and 39 viral miRNAs from the Sanger
database (Version 10.1), using the one-color technique in
accordance with the manufacturer’s Instructions. Total RNA
including enriched miRNA (100 ng) was dephosphorylated with
calf intestine alkaline phosphatase (GE Healthcare Europe
GmbH), denatured with dimethyl sulfoxide, and labeled with
pCp-Cy3 using T4 RNA ligase (GE Healthcare Europe GmbH).
The labeled RNAs were hybridized to Mouse miRNA Micro-
arrays Agilent Technologies (Santa Clara, CA). After hybridiza-
tion and washing, the arrays were scanned with an Agilent
microarray scanner using high dynamic range settings as specified
by the manufacturer. Microarray results were extracted using
Agilent Feature Extraction software (v9.5.3.1) [36]. Undetected
probes were excluded from further analysis. Background-subtract-
ed intensities were normalized for detected miRNA probes using
the quantile method across all 16 microarray experiments.
Microarray data analysis
mRNA microarrays. To determine enriched biologic pro-
cesses, we applied gene set enrichment analysis (GSEA) to the
visceral fat mRNA microarray dataset of mice exposed to SF
(n=8) and controls (n=8) [37]. We performed random gene set
permutation (n=2000) using approximately 3200 curated gene
sets and 1400 Gene Ontology annotations. We chose a false
discovery rate (FDR, Q-value) threshold of ,5% for significance.
Since even using a strict FDR cutoff, many pathways and genes
were significantly enriched, we limited our analysis to subsets of
differentially expressed genes within each gene set that were the
primary drivers of the enrichment score, known as the leading
edge [38]. Furthermore, gene sets involved in similar functions
such as ‘‘insulin regulation’’ and ‘‘diabetes pathways’’ or
‘‘mitochondrion’’ and ‘‘oxidative phosphorylation’’ were com-
bined.
miRNA microarrays. We identified differentially expressed
miRNAs in visceral fat tissue of SF and control mice using a
Bayesian implementation of the parametric t-test combined with
FDR correction using Q-value (cutoff,5%). Gene targets for
differentially expressed miRNAs were computationally predicted
using the miRanda algorithm [39,40] as implemented in the
MicroCosm Target web resource (http://www.ebi.ac.uk/enright-
srv/microcosm/htdocs/targets/v5/) [41].
Schema for integrating mRNA-miRNA data. Figure 1
outlines our general model for mRNA-miRNA data integration.
This approach is based on two principles. First, we assume that the
expression of a given miRNA is anti-correlated with the mRNA
expression of its targets. This is a widely accepted and
experimentally verified supposition [42]. Second, unlike other
published methods based on tests identifying differential expres-
sion of individual genes, we select enriched gene sets from the
Sleep Disruption and Visceral Adipose Tissue
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proposed pathway-centric methodologies can be substituted for
GSEA in this step [43,44]. The rationale for this approach is the
recognition that biologic processes result from coordinated
activation of coherent sets of genes known as modules [45,46]—
a paradigm ideally captured thorough pathway enrichment
analysis. The final step of this procedure involves systematic
linkage of differentially expressed miRNAs to their corresponding
pathways based on the presence of predicted target genes within
enriched modules.
Network analysis. A genetic network was constructed for
the enriched ‘‘insulin regulation and diabetes pathways’’ module
based on experimentally verified gene product interactions derived
from Ingenuity [47] and STRING [48] knowledgebases. Insulin
was incorporated within the network to highlight its central
relationship with the other nodes.
Quantitative RT-PCR (qPCR)
qPCR analysis was performed for selected mRNAs and
miRNAs using ABI PRISM 7500 System (Applied Biosystems,
Foster City, CA). The same total RNA was used for both
microarray and qPCR experiments. To confirm candidate
mRNAs, cDNA was synthesized using one microgram of total
RNA using a High-Capacity cDNA Archive Kit (Applied
Biosystems, Foster City, CA). Ribosomal 18S rRNA, was used
as a reference gene to normalize the expression ratios. All
experiments were performed in triplicates. The cycle number (Ct)
values were averaged and the difference between the 18S Ct and
the gene of interest Ct were calculated to calculate the relative
expression of the gene of interest using the 2
2DDCt method [49].
The results are presented as fold change (SF relative to control
conditions).
miRNAs selected for confirmation were reverse transcribed with
looped microRNA-specific reverse transcriptase (RT) primers
(Applied Biosystems, Foster City, CA) using the TaqMan
microRNA mouse assay according to the manufacturer’s protocol.
Briefly, RT reactions were performed in a volume of 15 ml, and
each reaction contained 10 ng of enrich miRNA. RT reactions
were performed on a GeneAmpPCR System 9600 (Applied
Biosystems, Foster City, CA). Reactions without addition of
reverse transcriptase were performed alongside cDNA synthesis of
each sample and used in subsequent procedures to control for
potential genomic DNA contamination. All TaqMan assays were
run in triplicate on an ABI Prism 7500 using TaqMan Universal
PCR Master Mix II without UNG (Applied Biosystems, Foster
City, CA). The qPCR results were normalized against an internal
control (RNU6), and then expressed as fold changes (SF relative to
control conditions).
Metabolic assessments
Metabolic parameters were measured in a different group of
control (n=8) and SF (n=7) mice following 6 hours of fasting
(with ad libitum access to water). Blood glucose and insulin levels
were measured immediately before glucose injection and the
homeostasis model assessment (HOMA) insulin resistance (IR)
equation (HOMA-IR index) was calculated [50]. For glucose
tolerance test (GTT), mice were injected with (2 g/kg) of D-
glucose (Sigma Chemical Co., St. Louis, MO) intra-peritoneally.
Blood samples were collected from lateral tail vein by puncture at
0, 15, 30, 60 and 120 min following the glucose injection. Glucose
levels were measured using a glucometer (One Touch Ultra,
Lifescan). Triglyceride levels were measured in an independent
group of control mice (n=5) and animals exposed to 3 weeks of SF
(n=5). Mice were fasted for 3 hours prior to blood collection.
Plasma triglyceride levels (mg/dl) were measured using Infinity kits
(Thermo Fisher Scientific, Waltham, MA) according to the
manufacturer’s protocol.
Statistical analysis
Two-tailed Mann-Whitney test with unequal variance was used
to compare HOMA-IR and plasma triglyceride levels between SF
and control mice (GraphPad Prism version 5, San Diego, CA).
The GTT time course experiment was analyzed using two-way
ANOVA with time and exposure (SF, control) as variables. The
ANOVA P-value reported corresponds to the significance of
exposure effect. All data are shown as mean 6 SEM.
Results
SF elicits differential expression of miRNAs in visceral
adipose tissue
We identified 19 differentially expressed miRNAs (9 up-
regulated, 10 down-regulated) in response to SF in visceral fat
cells using a Q-value cutoff ,5% (Figure 2). We confirmed the
differential expression of several candidate miRNAs using qPCR
as presented in Table 1.
Exposure to SF alters the transcriptional profile of visceral
adipocytes and is associated with enrichment of specific
pathways
We applied GSEA to mRNA probesets matching to unique
genes and demonstrated that SF induced profound transcriptional
Figure 1. Outline of a general approach for integrating mRNA-
miRNA data. Concurrent miRNA and mRNA profiling of the same
tissue under control and exposure conditions is performed. The mRNA
information is processed using gene set enrichment analysis with
further refinements based on leading edges of enriched biologic
modules. Meanwhile, differentially expressed miRNAs as well as their
computationally-derived targets are also identified. These data are then
merged based on anti-correlated expression of leading edge genes and
their corresponding putative miRNAs.
doi:10.1371/journal.pone.0037669.g001
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for select candidate genes using qPCR (Table 2). Subsequent
leading edge analysis identified two distinct patterns of differential
gene expression, each associated with enrichment of select gene
sets in mice exposed to SF or controls (enrichment Q-value,5%).
Biologic modules comprised of up-regulated genes in response to
SF included ‘‘mitochondrion and oxidative phosphorylation’’,
‘‘insulin regulation and diabetes pathways’’, ‘‘lipoprotein biosyn-
thesis and protein lipidation’’ and ‘‘proteasome pathways’’.
Modules enriched in genes down-regulated during exposure to
SF included ‘‘fatty acid metabolism and regulation by PPARa’’,
‘‘glycolytic pathways’’, ‘‘DNA binding and chromosomal organi-
zation’’, ‘‘cytoskeleton and extracellular matrix’’, ‘‘Rho and Ras
GTPase activity’’ and ‘‘complement pathways’’.
miRNA-mRNA data integration identifies putative
regulators of SF-induced pathways
As outlined in Figure 1 and discussed in the Methods section, we
systematically linked differentially expressed miRNAs with gene
members of enriched pathways based on anti-correlated expres-
sion levels. Figure 2 summarizes our results and highlights putative
regulatory relationships between miRNAs and their corresponding
biologic pathways in visceral adipose tissue of sleep-fragmented
mice. All differentially expressed miRNAs were associated with at
least one enriched pathway and in many instances interacted with
multiple modules.
Network analysis reveals control sites of a representative
enriched pathway
To further elucidate relationships among members of gene sets,
we constructed a gene product interaction network, or inter-
actome, for the ‘‘insulin regulation and diabetes’’ module. As
depicted in Figure 3, this interactome—like many biologic
networks [51]—was characterized by a few densely connected
hubs and several distinct motifs representing key functional units
including NADH dehydrogenase, ribosomal activity, ATP syn-
thase, and cytochrome c oxidase. Importantly, many members of
Figure 2. Integrated mRNA-miRNA analysis of visceral fat tissue transcriptome during SF. Heatmaps depict gene expression profiles of
enriched pathways and differentially expressed miRNAs in response to SF. The miRNAs are linked to their respective modules based on whether these
pathways harbor target genes. Note that one mRNA microarray experiment was excluded due to poor hybridization (gray column).
doi:10.1371/journal.pone.0037669.g002
Table 1. qPCR confirmation of selected differentially
expressed miRNAs.
Microarray qPCR
P-value Fold P-value Fold
mmu-miR-29b 5.4610
24 21.68 1.0610
22 21.59
mmu-miR-350 2.4610
24 21.54 4.0610
23 20.46
mmu-miR-185 3.9610
23 21.46 2.0610
23 21.47
mmu-miR-154 2.5610
27 2.39 2.0610
23 2.79
mmu-miR-300 1.4610
26 1.95 3.0610
23 2.16
mmu-miR-434-3p 2.8610
27 2.42 2.0610
23 3.79
doi:10.1371/journal.pone.0037669.t001
Table 2. qPCR confirmation of selected differentially
expressed genes.
Microarray qPCR
P-value Fold P-value Fold
Mlx 6.6610
23 1.46 5.4610
23 1.84
Gja4 2.2610
26 2.11 1.0610
23 2.79
Mt1 5.6610
26 2.69 3.0610
23 2.16
Srpk2 4.1610
26 2.40 2.0610
23 3.79
Cxcl13 1.7610
26 28.58 5.0610
23 23.67
Aldh2 1.3610
28 25.79 3.0610
23 24.22
Acaca 5.6610
26 23.99 2.0610
23 23.78
doi:10.1371/journal.pone.0037669.t002
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central role played by this molecule. Superimposed on the ‘‘insulin
regulation and diabetes’’ interactome were differentially expressed
miRNAs postulated to regulate its biologic function. We observed
that a member of this module, MAX-like protein X (MLX),
interacted with glucagon (GCG)—a central regulator of glucose
homeostasis—and was the most highly connected putative target
of miRNAs in the network, being linked to mmu-miR-29b, mmu-
miR-29c, and mmu-miR-350 (Figure 3). We confirmed the anti-
correlated expression pattern of two of these miRNAs and Mlx
using qPCR (Tables 1 and 2). Our findings implied that since Mlx
was a differentially upregulated gene and the putative target of
multiple downregulated miRNAs, it may play an important
regulatory role in the ‘‘insulin regulation and diabetes’’ module—a
prediction that is supported by recent reports [52,53].
Functional validation of dysregulated glucose and lipid
homeostasis following SF
Since our computational analyses highlighted perturbations in
‘‘insulin regulation and diabetes’’ gene set during exposure to SF,
we proceeded to compare metabolic measures of glucose
homeostasis in SF and control mice. As shown in Figures 4 and
5, animals exposed to 6 hours of SF developed significant insulin
resistance and impairment of glucose tolerance. Another enriched
module, comprised of downregulated genes after SF, was ‘‘fatty
acid metabolism and regulation by PPARa’’ (Figure 2). We have
observed systemic disturbances in lipid profiles of mice after
chronic exposure to SF (unpublished data) and therefore measured
fasting plasma triglyceride levels in mice following 3 weeks of SF.
As depicted in Figure 6, mice subjected to chronic SF had
significant elevation of their triglyceride levels, implying dysreg-
ulated lipid metabolism.
Discussion
In this study, we report on the first systematic effort to map the
regulatory transcriptional landscape of visceral adipocytes in
response to sleep fragmentation—a key pathophysiologic event
in sleep apnea. To achieve this aim, we developed a framework for
integrating mRNA-miRNA expression profiles based on gene set
enrichment and network analyses. Our results demonstrated that
exposing mice to SF induced widespread alterations in their fat cell
transcriptome and was associated with enrichment of distinct
pathways.
Although obstructive sleep apnea is associated with insulin
resistance, impaired glucose tolerance, and type 2 diabetes [54–
56], the role of SF in contributing to these metabolically
dysfunctional states is not known. Our findings suggest that SF
promotes metabolic disturbances by perturbing regulatory net-
works in visceral adipose tissue—including those involved in
Figure 3. Network analysis of the ‘‘insulin regulation and diabetes’’ pathway. Members of this enriched module were linked together
based on verified gene product interactions. Several distinct motifs were identified (shown in different colors). As expected, insulin assumed a central
position in this network. One upregulated candidate, MLX (red), was the putative target of multiple downregulated miRNAs (blue) and is postulated
to be a critical controller of visceral adipocytes’ metabolic response to SF. Note that several other downregulated miRNAs interacted with members of
this network, but are not shown in order to improve clarity.
doi:10.1371/journal.pone.0037669.g003
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gene product relationships allowed us to fine-map putative
interactions in the enriched ‘‘insulin regulation and diabetes’’
module, and identify potentially important metabolic effectors
induced by SF. One such candidate, MLX, is a component of a
heterodimeric transcription factor that is a master sensor of
cellular energy status and regulator of glucose metabolism
[52,53,57]. In our animal model of SF, MLX was upregulated
in visceral adipocytes and was a putative target of several
differentially expressed miRNAs. While the biological roles of
miRNAs in adipose tissue remain mostly unknown, reduced
circulating levels of one of the MLX-regulating miRNAs—mmu-
mir-29b—has been associated with the development of type 2
diabetes [58], and the mmu-mir-29 family may be involved in
insulin signaling [59]. We confirmed that following acute
exposures to SF, mice develop insulin resistance and glucose
intolerance. Future work will be required to determine the
molecular mechanisms mediated by candidate genes and miRNAs
highlighted from our analysis that lead to the observed metabolic
dysregulation. There is increasing evidence that circulating levels
of miRNAs may be useful diagnostic and prognostic biomarkers
for common human disorders including obesity [60], diabetes [58]
and cardiovascular diseases [61], although no study to date has
investigated a role for miRNAs in sleep apnea.
In addition to the ‘‘insulin regulation and diabetes’’ gene set, we
identified several other enriched modules comprised of differen-
tially upregulated genes in response to SF, including ‘‘mitochon-
drion and oxidative phosphorylation’’ and ‘‘proteasome’’ gene
sets. These finding are consistent with our recent report identifying
these pathways as highly activated in visceral adipose tissue of mice
exposed to intermittent hypoxia [62]. Since intermittent hypoxia
and SF represent two critical perturbations in sleep apnea, the
overlapping of enriched gene sets implies that at the functional
pathway level, these insults promote similar alterations in
adipocyte biology.
It is important to note that while adipose tissue is a critical
regulator of glucose metabolism, many other organs such as the
liver, pancreas, hypothalamus, and skeletal muscle are also
important contributors. It is therefore highly likely that SF also
alters the transcriptional response within these tissues. Compre-
hensive profiling of other metabolic regulators was not within the
scope of this project and represents a future direction. Neverthe-
less, adipose tissues in general, and visceral fat in particular, are
widely regarded as the orchestrator of lipid storage and
metabolism—primarily in the form of triacylglycerol (triglyceride).
To assess whether SF is associated with adipose tissue dysfunction,
we measured plasma triglyceride levels in mice subjected to 3
weeks of SF and found that chronic sleep disruption resulted in
significant elevation of circulating triglycerides (Figure 6). Consis-
tent with this observation, our computational analyses had
identified ‘‘fatty acid metabolism and regulation by PPARa’’ as
an enriched gene set with most of its members down-regulated in
response to SF (Figure 2). Peroxisome proliferator-activated
receptor-alpha (PPARa) is a key controller of lipid metabolism
[63] and can be pharmacologically activated by fibrates—a class of
Figure 4. Acute sleep fragmentation causes dysregulation in
glucose homeostasis as demonstrated by the development of
insulin resistance in SF mice using the homeostatic model
assessment (HOMA-IR). Data are presented as mean 6 SEM.
doi:10.1371/journal.pone.0037669.g004
Figure 5. Reduced glucose tolerance in mice exposed to SF
compared to control animals. Mice (n=8 control, n=7 SF) were
injected with of D-glucose (2 g/kg) intra-peritoneally and glucose levels
measured at 0, 15, 30, 60 and 120 min following injection. P-value was
based on two-way ANOVA and corresponds to the significance of
exposure (glucose) effect. All data are shown as mean 6 SEM.
doi:10.1371/journal.pone.0037669.g005
Figure 6. Chronic sleep fragmentation is associated with
elevated circulating triglycerides. Mice were subjected to 3 weeks
of SF (n=5) or used as controls (n=5). Fasting plasma triglyceride levels
were measured and are presented as mean 6 SEM.
doi:10.1371/journal.pone.0037669.g006
Sleep Disruption and Visceral Adipose Tissue
PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37669drugs used clinically to lower triglyceride level. Our findings
suggest that this pathway may also represent a potential
therapeutic target for sleep apnea-associated dyslipidemia.
In this work, we outlined a simple strategy to integrate data
from concurrent mRNA and miRNA profiling of the same tissue.
Unlike previous methods based on gene-level statistics, we
implemented a gene set enrichment approach because most
biologic processes result from coordinated activation of many
genes [45]. Importantly, since a given miRNA has multiple targets,
our methodology is ideally suited to capture the role of these
regulatory molecules in the context of functionally relevant
pathways. Furthermore, this approach is quite flexible (e.g., other
enrichment algorithms or metrics for differential gene expression
can be substituted) and is generalizable to any in vivo or in vitro
experimental system.
This study has several limitations. Exposure to SF was short
(6 hours); future work is required to investigate the chronic effects
of SF on adipose tissue and metabolism. Although we confirmed
differential expression of several candidates using qPCR, we did
not measure differences at the protein level. Furthermore, miRNA
targets were identified based on computational predictions and not
functionally validated. Finally, our enrichment and network
analyses represented the current state of knowledge. Since many
new relationships between gene products and pathways will be
discovered in the future, the presented network analyses capture a
subset of the biologic processes activated in this model.
In conclusion, we demonstrate that a short exposure to sleep
fragmentation perturbs the transcriptional circuitry of visceral
adipocytes and induces metabolic dysregulation in mice. We
propose a general strategy to integrate whole-genome mRNA and
miRNA profiling, and exploit this method to systematically map
genetic networks in fat tissue and identify pathways induced by SF
in the context of regulatory miRNAs.
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